Results 151 to 160 of about 195 (181)

Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy

open access: yesHead &Neck, EarlyView.
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona   +5 more
wiley   +1 more source

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis

open access: yesIbrain, Volume 11, Issue 1, Page 74-83, Spring 2025.
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley   +1 more source

Neoplasms of the Peripheral Nervous System

Clinics in Podiatric Medicine and Surgery, 1990
Neoplasms of the peripheral nervous system arise from the cellular sheath surrounding the nerve trunks, that is, the pluripotential Schwann cells and related cells, and rarely affect the feet. When present, they are most frequently associated with the autosomal dominantly inherited neurofibromatosis 1.
G K, Potter, J S, Feldman
openaire   +4 more sources

Central and peripheral nervous system neoplasms

2015
Derek C. Knottenbelt   +2 more
openaire   +3 more sources

Immunolocalization of Laminin in Neoplasms of the Central and Peripheral Nervous Systems

Journal of Neuropathology and Experimental Neurology, 1985
Laminin is a basement membrane glycoprotein that is expressed in vitro by immature and neoplastic astrocytes. The expression of laminin in vivo was examined immunohistochemically in normal adult brain and 90 neoplasms of the central and peripheral nervous systems.
R D, McComb, D D, Bigner
openaire   +2 more sources

An experimental model for selective production of neoplasms of the peripheral nervous system

Acta Neuropathologica, 1973
Ninety-three tumors of the peripheral nervous system (PNS) were produced in 30 male Fischer (CDF) rats following intravenous injection of 10 mg/kg of N-methyl N-nitrosourea (MNU) twice weekly for 9 weeks. The high susceptibility of CDF rats to an optimal dose of MNU provides a useful experimental model to study induction and pathogenesis of tumors of ...
R H, Denlinger   +2 more
openaire   +2 more sources

Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms

Advances in Anatomic Pathology, 2018
The diagnosis of a neurofibroma or a malignant peripheral nerve sheath tumor (MPNST) often raises the question of whether the patient has the genetic disorder neurofibromatosis type 1 (NF1) as well as how this will impact the patient’s outcome, what their risk is for developing additional neoplasms and whether treatment options differ for NF1 ...
Jody F, Longo   +3 more
openaire   +2 more sources

Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems

Annals of Diagnostic Pathology, 2003
Many different types of small cell, embryonal, and poorly differentiated neoplasms originate within the central and peripheral nervous systems. Because appropriate treatment is based on a correct diagnosis, the surgical pathologist must be familiar both with basic characteristics of each of the numerous entities as well as the spectrum of morphologic ...
Hannes, Vogel, Gregory N, Fuller
openaire   +2 more sources

T-cell receptor V-gene usage in neoplasms of the central nervous system

Journal of Neurosurgery, 1993
✓ The use of tumor-infiltrating lymphocytes in the treatment of central nervous system (CNS) neoplasms has met with serious obstacles due to difficulty of culture and poor characterization. Since in other tumors the therapeutic effects of tumor-infiltrating lymphocytes have been shown to rely on T-cell receptor engagement, the authors addressed the ...
Merlo A   +8 more
openaire   +3 more sources

The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.

The American journal of pathology, 2016
Comprehensive genomic analyses of common nervous system cancers provide new insights into their pathogenesis, diagnosis, and treatment. Although analogous studies of rare nervous system tumors are needed, there are major barriers to performing such studies.
openaire   +1 more source

Home - About - Disclaimer - Privacy